ABSTRACT
Nanomedicine is a rapidly growing field in the area of diagnostics, imaging, and targeted therapeutic approaches for the basis of the pathophysiology of gastrointestinal diseases. Nanocarriers capable of delivering of anti-inflammatory drugs specifically to gastrointestinal tract affected region for a prolonged period of time reduces the side effects of encapsulated drugs. Therefore, the present book chapter provides in details on various gastric disorders and their pathophysiology on the recent development of nanomedicines for the detection and treatment of gastrointestinal diseases.
